Nilo Therapeutics, which launched Wednesday, is trying to develop drugs that regulate inflammation and the immune system by ...

AstraZeneca plans to build a factory in Albemarle County at a site near UVA’s North Fork, a research park with numerous ...

The institute broke ground on a new Camden-based life sciences campus on Thursday. The building will support Coriell's ...

Is biotech back? And how did a math error cost AstraZeneca a rare disease candidate? All that and more on the new episode of ...

Pharmaceutical and biotech companies have seen a shrinking share of investments across the five boroughs in the first half of ...

Ypsomed AG, a Swiss developer and manufacturer of injection systems for the self-administration of liquid medication, ...

In a move to catalyze growth in one of New Haven’s most promising industries, Gov. Ned Lamont and the Connecticut Department ...

MIT professor and serial entrepreneur Bob Langer has launched, Soufflé Therapeutics which aims to rise to the challenge of ...

The expiration of the SBIR program comes as New York’s burgeoning life sciences market races to catch up to major biotech hubs across the country. The city has long lagged behind cities including ...

BIOSPAIN showed how partnering conferences connect public funding, venture capital, and pharma to drive biotech innovation to ...

“North Carolina is a global leader in life sciences, and Biogen has been at the heart of that story for three decades,” Stein ...

An update from MAIA Biotechnology, Inc. ( ($MAIA) ) is now available. On October 7, 2025, MAIA Biotechnology, Inc. announced a new digital asset ...